Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis

NCT04840485 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

548

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: SHR-1314
DRUG: SHR-1314
DRUG: Placebo

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.